The following data is part of a premarket notification filed by Biowave Corporation with the FDA for Deepwave Percutaneous Neuromodulation Pain Therapy System.
| Device ID | K061166 |
| 510k Number | K061166 |
| Device Name: | DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM |
| Classification | Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief |
| Applicant | BIOWAVE CORPORATION 49 PLAIN STREET North Attleboro, MA 02760 |
| Contact | Mary Mcnamara-cullinane |
| Correspondent | Mary Mcnamara-cullinane BIOWAVE CORPORATION 49 PLAIN STREET North Attleboro, MA 02760 |
| Product Code | NHI |
| CFR Regulation Number | 882.5890 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2006-04-27 |
| Decision Date | 2006-08-15 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00859911006065 | K061166 | 000 |
| 10859911006024 | K061166 | 000 |
| 20859911006007 | K061166 | 000 |